| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1100381838 |
| P356 | DOI | 10.1186/S12974-018-1053-4 |
| P932 | PMC publication ID | 5767033 |
| P698 | PubMed publication ID | 29329581 |
| P2093 | author name string | Guohui Lu | |
| Shizhong Zhang | |||
| Xiaozheng He | |||
| Fengfei Lu | |||
| Hengxu Mao | |||
| Yongyi Ye | |||
| Longping Yao | |||
| P2860 | cites work | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs | Q26801035 | ||
| RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS | Q28279898 | ||
| Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
| A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 | ||
| Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 | Q28594813 | ||
| Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
| Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease | Q29614900 | ||
| Neuroinflammation in Parkinson's disease: a target for neuroprotection? | Q29616300 | ||
| Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia/reperfusion injury | Q48311927 | ||
| Microglial P2X₇ receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat. | Q48406439 | ||
| The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. | Q48770351 | ||
| Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10 | Q73242294 | ||
| Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo | Q73760293 | ||
| Neuroinflammation Induces Neurodegeneration | Q89925183 | ||
| Microglial physiology: unique stimuli, specialized responses | Q29620417 | ||
| MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. | Q30937357 | ||
| New insights into the role of histamine in subventricular zone-olfactory bulb neurogenesis | Q33760277 | ||
| Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. | Q34026906 | ||
| The essential role of MEKK3 in TNF-induced NF-kappaB activation | Q34082436 | ||
| A macrophage NBR1-MEKK3 complex triggers JNK-mediated adipose tissue inflammation in obesity | Q34143227 | ||
| MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. | Q34197681 | ||
| Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease | Q34535020 | ||
| MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. | Q34606028 | ||
| Presenilin 2 influences miR146 level and activity in microglia | Q35137238 | ||
| MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death | Q35583229 | ||
| Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease | Q35808960 | ||
| A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease | Q36125335 | ||
| MicroRNA-124 as a novel treatment for persistent hyperalgesia | Q36161510 | ||
| Testing NF-κB-based therapy in hemiparkinsonian monkeys | Q36166141 | ||
| Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior | Q36335668 | ||
| Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease | Q36537780 | ||
| microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. | Q36610305 | ||
| Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease | Q36659955 | ||
| Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein | Q36718966 | ||
| MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines | Q37279851 | ||
| MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. | Q37609283 | ||
| Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases. | Q38182337 | ||
| Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases | Q38322767 | ||
| MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim. | Q38874732 | ||
| The role of microRNA in neuronal inflammation and survival in the post ischemic brain: a review | Q39334671 | ||
| Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-α and NF-κB nuclear translocation in BV-2 microglia | Q39391666 | ||
| MEKK3 regulates IFN-gamma production in T cells through the Rac1/2-dependent MAPK cascades | Q39563020 | ||
| The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | Q40074115 | ||
| Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells | Q40344505 | ||
| Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model. | Q42941982 | ||
| Neurological disorders: microRNA gets motoring | Q43592120 | ||
| The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia | Q44338722 | ||
| Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins. | Q46898533 | ||
| Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. | Q47191620 | ||
| MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease | Q47423116 | ||
| The pro-differentiating role of miR-124: indicating the road to become a neuron | Q48176430 | ||
| P433 | issue | 1 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| microRNA | Q310899 | ||
| P304 | page(s) | 13 | |
| P577 | publication date | 2018-01-12 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease | |
| P478 | volume | 15 |
| Q88938163 | Decreased MiR-128-3p alleviates the progression of rheumatoid arthritis by up-regulating the expression of TNFAIP3 |
| Q93197671 | Downregulated lncRNA-SNHG1 enhances autophagy and prevents cell death through the miR-221/222 /p27/mTOR pathway in Parkinson's disease |
| Q98771666 | Engineered Extracellular Vesicles Loaded With miR-124 Attenuate Cocaine-Mediated Activation of Microglia |
| Q91693416 | Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases |
| Q89494159 | MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders |
| Q92850322 | Protodioscin protects PC12 cells against oxygen and glucose deprivation-induced injury through miR-124/AKT/Nrf2 pathway |
| Q91580885 | TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation |
| Q90461848 | The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q92431578 | miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease |
| Q61810937 | miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells |
Search more.